-5%
Liverty Tablet is indicated for adult patients with primary biliary cholangitis (PBC):
- Without cirrhosis, or
- With compensated cirrhosis (no evidence of portal hypertension).
It is used: - In combination with ursodeoxycholic acid (UDCA) for those with an inadequate response to UDCA.
- As monotherapy for patients intolerant to UDCA.

